R. Mehran

发表

ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike.

M. Krucoff, D. Cao, R. Mehran, 2022, EuroIntervention.

Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry.

G. Dangas, I. Iakovou, A. Kini, 2022, EuroIntervention.

Troponin in Stable Patients Undergoing Coronary Angiography: Should It Be Routinely Assessed?

A. Spirito, Rebecca E. Cohen, R. Mehran, 2022, Journal of the American Heart Association.

Best Practices for Designing Informative Trials Including Women

B. Vogel, J. Nicolas, M. Edens, 2022, Current Atherosclerosis Reports.

British Cardiovascular Interventional Society Consensus: a Huge Step Towards Standardised Care for Out-of-hospital Cardiac Arrest in the UK

M. Noc, R. Mehran, 2022, Interventional Cardiology: Reviews, Research, Resources.

Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win‐ratio analysis of the PARADISE‐MI trial

M. Pfeffer, G. Filippatos, J. McMurray, 2022, European journal of heart failure.

Diabetes mellitus in transfemoral transcatheter aortic valve implantation: a propensity matched analysis

G. Dangas, R. Kornowski, S. Sartori, 2022, Cardiovascular Diabetology.

The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial

M. Pfeffer, J. McMurray, J. Rouleau, 2022, Circulation.

Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials

P. Serruys, G. Stone, M. Leon, 2022, Journal of the American Heart Association.

Device and Procedure Relatedness: Viewpoint From Members of the ARC Steering Group.

M. Krucoff, M. Morice, D. Cutlip, 2022, JACC. Cardiovascular interventions.

Prevention and Management of Stroke After Transcatheter Aortic Valve Replacement: The Mount Sinai Stroke Initiative.

Samin K. Sharma, G. Dangas, A. Kini, 2023, Journal of the American Heart Association.

Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review.

Deepak L. Bhatt, W. Ageno, G. Lippi, 2022, JAMA cardiology.

Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications

R. de Caterina, D. Angiolillo, C. Gibson, 2022, Expert review of clinical pharmacology.

Clinical Pharmacokinetics and Pharmacodynamics of CSL112

D. Angiolillo, C. Gibson, D. Capodanno, 2023, Clinical Pharmacokinetics.

Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study.

M. Krucoff, A. Kastrati, G. Dangas, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside.

D. Cao, J. Nicolas, M. Chiarito, 2022, Cardiovascular research.

Role and relevance of risk stratification models in the modern-day management of non-ST elevation acute coronary syndromes

V. Kunadian, C. Wilkinson, Roxana Mehran, 2022, Heart.

This is a repository copy of Antithrombotic therapy after acute coronary syndrome or PCI

A. Parkhomenko, C. Granger, A. Budaj, 2019 .

Sex-based Differences in Percutaneous Coronary Intervention Outcomes in Patients with Ischaemic Heart Disease

B. Vogel, V. Kunadian, A. Chieffo, 2023, European cardiology.

On‐Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two‐Year Results From ADAPT‐DES

Peter L Duffy, G. Stone, F. Neumann, 2022, Journal of the American Heart Association.

Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials.

G. Patti, M. Mennuni, Leonardo Grisafi, 2022, European heart journal. Cardiovascular pharmacotherapy.

The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive.

H. Thiele, J. Collet, R. Mehran, 2022, European heart journal.

Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort.

Samin K. Sharma, J. Wykrzykowska, J. Mehilli, 2022, International journal of cardiology.

Artificial Intelligence – Advisory or Adversary?

B. Vogel, J. Nicolas, R. Mehran, 2023, Interventional cardiology.

Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial.

Sunil V. Rao, J. Spertus, D. Wood, 2022, JAMA cardiology.

Two‐year clinical outcomes after successful transcatheter aortic valve implantation with balloon‐expandable versus self‐expanding valves: A subanalysis of the GALILEO trial

J. Tijssen, G. Dangas, S. Windecker, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies.

N. Desai, H. Herrmann, P. Groeneveld, 2022, JAMA cardiology.

Edge‐to‐edge percutaneous mitral repair for functional ischaemic and non‐ischaemic mitral regurgitation: a systematic review and meta‐analysis

C. Di Mario, A. Colombo, D. Cao, 2022, ESC heart failure.

Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.

Deepak L. Bhatt, G. Stone, S. Windecker, 2022, European heart journal.

Antiplatelet therapy for coronary artery disease in 2023: current status and future prospects

James W. Johnson, B. Vogel, R. Chandiramani, 2023, Expert review of cardiovascular therapy.

Antiplatelet Therapy in High-Bleeding Risk Patients Undergoing PCI: Walking a Tightrope

D. Cao, J. Nicolas, F. Beerkens, 2022, Reviews in cardiovascular medicine.

Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom

Samin K. Sharma, G. Dangas, A. Kini, 2022, Journal of clinical medicine.

Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease

Samin K. Sharma, G. Dangas, A. Kini, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations.

P. Serruys, G. Stone, J. Garot, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium

Deepak L. Bhatt, P. Serruys, M. Krucoff, 2023, Circulation.

Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.

J. Saw, J. Peper, M. Ruel, 2022, JAMA.

Sirolimus‐coated balloon versus everolimus‐eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial

A. Greco, B. Cortese, J. M. de la Torre Hernández, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Women leaders: transforming the culture in cardiology

C. Grines, B. Bozkurt, N. Wenger, 2022, Open Heart.

Validation of UK-BCIS CHIP Score to Predict 1-Year Outcomes in a Contemporary United States Population.

Samin K. Sharma, A. Kini, S. Sartori, 2023, JACC. Cardiovascular interventions.

Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of glassy and twilight.

A. Kastrati, G. Dangas, S. Windecker, 2023, International journal of cardiology.

Clinical Pharmacokinetics and Pharmacodynamics of CSL112

D. Angiolillo, C. Gibson, D. Capodanno, 2023, Clinical Pharmacokinetics.

Outcomes After Transcatheter Aortic Valve Implantation in Men Versus Women.

C. Hengstenberg, J. Tijssen, G. Dangas, 2022, The American journal of cardiology.

Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial

G. Condorelli, R. Piccolo, M. Federici, 2023, Cardiovascular Diabetology.

Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI.

P. Serruys, G. Stone, A. Kastrati, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Elderly patients with acute myocardial infarction: Targeted or complete revascularization?

A. Spirito, Roxana Mehran, R. Mehran, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Invasive Versus Medical Management in Patients With Chronic Kidney Disease and Non–ST‐Segment–Elevation Myocardial Infarction

S. Bangalore, R. Puri, A. Kalra, 2022, Journal of the American Heart Association.

Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis

E. Tremoli, C. Gibson, D. Angiolillo, 2022, Thrombosis and Haemostasis.

Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial.

C. Granger, S. Windecker, R. Lopes, 2022, JAMA cardiology.

Trends in Vascular Access Site Use and Outcomes in Patients Undergoing PCI.

Samin K. Sharma, G. Dangas, A. Kini, 2023, The American journal of cardiology.

Migraine and cardiovascular disease: what cardiologists should know.

R. D. de Winter, B. Vogel, D. Kalkman, 2023, European heart journal.

Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding.

Deepak L. Bhatt, D. Cao, M. Chiarito, 2023, European heart journal.

Depression and ischemic heart disease.

D. Cao, J. Nicolas, R. Chandiramani, 2022, International journal of cardiology.

Recent Advances in Antiplatelet Therapy in Complex Percutaneous Coronary Intervention.

D. Cao, J. Nicolas, A. Spirito, 2022, Interventional cardiology clinics.

Representation of Women in Cardiology Academic Faculty Ranks.

P. Parikh, Dee Dee Wang, S. E. Altin, 2023, American Journal of Cardiology.

The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study

A. Abizaid, N. Lopes, R. Filho, 2023, Diabetology & Metabolic Syndrome.

Percutaneous Coronary Intervention in Men, Women, and Minorities With a Previous Coronary Artery Bypass Graft Surgery (from the Pooled PLATINUM Diversity and PROMUS Element Plus Registries).

Sarabjeet Singh, G. Dangas, D. Kandzari, 2023, The American journal of cardiology.

Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic Review.

H. Herrmann, M. Faggioni, Alexander C. Fanaroff, 2023, JAMA cardiology.

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease: 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Association for Acute CardioVascular Care (ACVC) and European Association of Pr

D. Atar, V. Aboyans, S. Windecker, 2023, European Heart Journal - Cardiovascular Pharmacotherapy.

Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary Syndrome.

M. Valgimigli, C. Briguori, G. Esposito, 2023, JACC. Cardiovascular interventions.

Provisional Strategy for Left Main Stem Bifurcation Disease: A State-of-the-Art Review of Technique and Outcomes.

D. Kandzari, P. Smits, D. Cao, 2023, JACC. Cardiovascular interventions.

Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes.

Samin K. Sharma, V. Fuster, I. Palacios, 1996, Circulation.

PROGNOSTIC VALUE OF HIGH-SENSITIVITY C-REATIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION.

Samin K. Sharma, G. Dangas, A. Kini, 2023, Journal of cardiology.

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.

Deepak L. Bhatt, H. Schunkert, A. Kastrati, 2023, Journal of the American College of Cardiology.

2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.

J. McMurray, J. Emberson, M. Czerny, 2023, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Impact of Clinical Presentation on Outcomes After Rotational Atherectomy in Patients Who Underwent Percutaneous Coronary Intervention.

Samin K. Sharma, A. Kini, S. Sartori, 2023, The American journal of cardiology.

Clinical features and prognosis of patients with spontaneous coronary artery dissection.

Kipp W. Johnson, Deepak L. Bhatt, R. Mehran, 2020, International journal of cardiology.

Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry.

S. Pocock, T. Henry, M. Krucoff, 2019, JACC. Cardiovascular interventions.

The Smart(est) Choice for Dual Antiplatelet Therapy is a Patient-Directed One.

A. Kirtane, R. Mehran, 2022, JAMA cardiology.

Dear colleagues: enough with the men-only author panels

H. V. Van Spall, J. Januzzi, R. Mehran, 2022, European heart journal supplements : journal of the European Society of Cardiology.

Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors

Deepak L. Bhatt, P. Ellinor, A. Keech, 2023, Journal of the American College of Cardiology.

Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials

M. Valgimigli, R. Stables, D. Erlinge, 2023, Circulation.

1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI.

S. Bangalore, B. Vogel, S. Sartori, 2023, JACC. Cardiovascular interventions.

Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial

S. Mehta, V. Kunadian, P. Steg, 2023, Circulation. Cardiovascular interventions.

Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: an EAPCI position statement in collaboration with EHRA, EACVI, the ESC Regulatory Affairs Committee and Women as One.

G. Pontone, C. Leclercq, D. Dudek, 2022, EuroIntervention.

Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE‐MI

M. Pfeffer, J. McMurray, C. Granger, 2023, Journal of the American Heart Association.

Significance of Kidney Disease in Cardiovascular Disease Patients.

B. Vogel, R. Chandiramani, A. Spirito, 2023, Interventional cardiology clinics.

Whole-genome sequencing uncovers two loci for coronary artery calcification and identifies ARSE as a regulator of vascular calcification

May E. Montasser, Nicholette D. Palmer, Caitlin P. McHugh, 2023, Nature Cardiovascular Research.

Ticagrelor With or Without Aspirin Following Percutaneous Coronary Intervention in High-Risk Patients With Concomitant Peripheral Artery Disease: a subgroup analysis of the TWILIGHT randomized clinical trial.

G. Dangas, U. Baber, B. Vogel, 2024, American heart journal.

Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention.

G. Dangas, A. Kini, B. Vogel, 2024, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Reply: Unconvinced by Data or Resistance to Change?

Felice Gragnano, Paolo Calabrò, R. Mehran, 2024, Journal of the American College of Cardiology.

Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review

B. Vogel, D. Cao, J. Nicolas, 2023, Pharmacogenomics and personalized medicine.

Comparing Anticoagulation Strategies for Venous Thromboembolism Associated With Active Cancer

G. Dangas, D. Sueta, K. Fujisue, 2024, JACC. CardioOncology.

Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures: JACC State-of-the-Art Review.

G. Dangas, S. Mohanty, Rachita Navara, 2024, Journal of the American College of Cardiology.

When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.

D. Angiolillo, B. Bikdeli, H. Krumholz, 2024, Journal of the American College of Cardiology.

Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table.

E. Samset, A. Kappetein, Jana Kurucova, 2024, European heart journal.

Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis.

G. Dangas, D. Angiolillo, D. Heg, 2024, JAMA cardiology.

G. Dangas, G. Weisz, U. Baber, 2023, JACC. Cardiovascular interventions.

Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina Pectoris.

Samin K. Sharma, G. Dangas, A. Kini, 2022, The American journal of cardiology.

Abbreviated dual antiplatelet therapy after PCI in patients at high bleeding risk: a collaborative meta-analysis of randomized trials

P. Steg, M. Valgimigli, D. Cao, 2022, European Heart Journal.

Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

Deepak L. Bhatt, G. Stone, S. Bangalore, 2023, Circulation. Cardiovascular interventions.

Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease.

Jacob E. Kurlander, M. Vaduganathan, A. Aminian, 2024, Nature reviews. Cardiology.

Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents.

Samin K. Sharma, G. Dangas, A. Kini, 2022, The American journal of cardiology.

Reply: Decoding Ticagrelor Dyspnea: Central Apnea Screening Before Drug Discontinuation.

U. Baber, D. Cao, R. Mehran, 2024, JACC. Cardiovascular interventions.

Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.

D. Angiolillo, J. T. ten Berg, D. Sibbing, 2021, European heart journal.

One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial.

J. Weinsaft, S. Pocock, D. Angiolillo, 2024, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis.

G. Dangas, D. Cao, A. Camaj, 2022, European heart journal. Cardiovascular pharmacotherapy.